Fabry disease: a disorder of childhood onset

Fabry disease, an X-linked disorder of glycosphingolipids, markedly increases the risk of systemic vasculopathy, ischemic stroke, small-fiber peripheral neuropathy, cardiac dysfunction, and chronic kidney disease. We performed an extensive PubMed search on the topic of Fabry disease and drew from ou...

Full description

Saved in:
Bibliographic Details
Main Authors: Schiffmann, Raphael (Author) , Ries, Markus (Author)
Format: Article (Journal)
Language:English
Published: July 2, 2016
In: Pediatric neurology
Year: 2016, Volume: 64, Pages: 10-20
ISSN:1873-5150
DOI:10.1016/j.pediatrneurol.2016.07.001
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.pediatrneurol.2016.07.001
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0887899416300534
Get full text
Author Notes:Raphael Schiffmann, MD, MHSc, Markus Ries, MD, PhD, MHSc

MARC

LEADER 00000caa a2200000 c 4500
001 1565286847
003 DE-627
005 20240316100305.0
007 cr uuu---uuuuu
008 171113s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.pediatrneurol.2016.07.001  |2 doi 
035 |a (DE-627)1565286847 
035 |a (DE-576)495286842 
035 |a (DE-599)BSZ495286842 
035 |a (OCoLC)1340982044 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schiffmann, Raphael  |e VerfasserIn  |0 (DE-588)111475126X  |0 (DE-627)869019376  |0 (DE-576)477474578  |4 aut 
245 1 0 |a Fabry disease  |b a disorder of childhood onset  |c Raphael Schiffmann, MD, MHSc, Markus Ries, MD, PhD, MHSc 
264 1 |c July 2, 2016 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.11.2017 
520 |a Fabry disease, an X-linked disorder of glycosphingolipids, markedly increases the risk of systemic vasculopathy, ischemic stroke, small-fiber peripheral neuropathy, cardiac dysfunction, and chronic kidney disease. We performed an extensive PubMed search on the topic of Fabry disease and drew from our cumulative 43 years of experience. Most of these complications are nonspecific in nature and clinically indistinguishable from similar abnormalities that occur in the context of more common disorders in the general population. This disease is caused by variants of the GLA gene, and its incidence may have been underestimated. However, one must also guard against overdiagnosis of Fabry disease and unjustified enzyme replacement therapy, because some of the gene variants are benign. Specific therapy for Fabry disease has been developed in the last few years, but its clinical effect has been modest. Novel therapeutic agents are being developed. Standard “nonspecific” medical and surgical therapy is necessary and effective in slowing deterioration or compensating for organ failure in patients with Fabry disease. Fabry disease is a treatable and modifiable genetic risk factor for a myriad of clinical organ complications. Fabry disease may be frequently overlooked but on occasion overdiagnosed. 
650 4 |a angiokeratoma 
650 4 |a genetic disease 
650 4 |a heart disease 
650 4 |a sphingolipids 
650 4 |a Stroke 
650 4 |a X-linked 
700 1 |a Ries, Markus  |d 1971-  |e VerfasserIn  |0 (DE-588)136385338  |0 (DE-627)582068479  |0 (DE-576)300993358  |4 aut 
773 0 8 |i Enthalten in  |t Pediatric neurology  |d Amsterdam [u.a.] : Elsevier Science, 1985  |g 64(2016), Supplement C, Seite 10-20  |h Online-Ressource  |w (DE-627)320518930  |w (DE-600)2014321-7  |w (DE-576)091017882  |x 1873-5150  |7 nnas  |a Fabry disease a disorder of childhood onset 
773 1 8 |g volume:64  |g year:2016  |g supplement:Supplement C  |g pages:10-20  |g extent:11  |a Fabry disease a disorder of childhood onset 
856 4 0 |u http://dx.doi.org/10.1016/j.pediatrneurol.2016.07.001  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0887899416300534  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20171113 
993 |a Article 
994 |a 2016 
998 |g 136385338  |a Ries, Markus  |m 136385338:Ries, Markus  |d 910000  |d 910500  |e 910000PR136385338  |e 910500PR136385338  |k 0/910000/  |k 1/910000/910500/  |p 2  |y j 
999 |a KXP-PPN1565286847  |e 2987105347 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1565286847","id":{"doi":["10.1016/j.pediatrneurol.2016.07.001"],"eki":["1565286847"]},"title":[{"subtitle":"a disorder of childhood onset","title":"Fabry disease","title_sort":"Fabry disease"}],"note":["Gesehen am 13.11.2017"],"person":[{"family":"Schiffmann","roleDisplay":"VerfasserIn","given":"Raphael","display":"Schiffmann, Raphael","role":"aut"},{"given":"Markus","display":"Ries, Markus","role":"aut","roleDisplay":"VerfasserIn","family":"Ries"}],"physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Raphael Schiffmann, MD, MHSc, Markus Ries, MD, PhD, MHSc"]},"relHost":[{"pubHistory":["1.1985 -"],"recId":"320518930","physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2016","extent":"11","pages":"10-20","text":"64(2016), Supplement C, Seite 10-20","volume":"64"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"Elsevier Science","dateIssuedKey":"1985","publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1985-"}],"language":["eng"],"disp":"Fabry disease a disorder of childhood onsetPediatric neurology","note":["Gesehen am 19.02.20"],"id":{"issn":["1873-5150"],"zdb":["2014321-7"],"eki":["320518930"]},"title":[{"title":"Pediatric neurology","title_sort":"Pediatric neurology"}]}],"origin":[{"dateIssuedDisp":"July 2, 2016","dateIssuedKey":"2016"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} 
SRT |a SCHIFFMANNFABRYDISEA2201